Status:

COMPLETED

Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery

Lead Sponsor:

Murdoch Childrens Research Institute

Conditions:

Hypoplastic Left Heart Syndrome

Heart Defects, Congenital

Eligibility:

All Genders

2-4 years

Phase:

PHASE1

Brief Summary

This study aims to evaluate the safety and feasibility of coronary infusion of autologous placental cord blood mononuclear cells during the Norwood heart operation in newborn hypoplastic left heart sy...

Detailed Description

This is a Phase I, open label safety study. Autologous cord blood mononuclear cells (stem cell containing, cord blood buffy coat fraction) was delivered by coronary infusion during the Norwood cardiop...

Eligibility Criteria

Inclusion

  • Male and females with antenatally diagnosed Hypoplastic Left Heart Syndrome (all types requiring Norwood operation)
  • Written informed consent by parents/legal guardian
  • Successful aseptic collection of autologous cord blood unit and transfer of buffy coat mononucleocyte fraction to cold storage pending cardiac surgery within 2-4 days

Exclusion

  • Patient:
  • does not have autologous cord blood cells available at the time of cardiopulmonary bypass surgery
  • has evidence of arrhythmia requiring anti-arrhythmia therapy
  • has an additional congenital diagnosis that contributes to conditions such as an immune system disorder, immune deficiency, complex metabolic disorder, brain dysplasia or progressive neurological degenerative disorder
  • has other clinical complexity deemed by the cardiac surgeon to make the patient unsuitable for inclusion in the trial
  • Mother:
  • • is serum positive for HIV, hepatitis or other significant pathogen and has known allergies to penicillin, streptomycin or other antibiotic

Key Trial Info

Start Date :

February 16 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2022

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03431480

Start Date

February 16 2018

End Date

June 30 2022

Last Update

July 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Children's Hospital

Melbourne, Victoria, Australia, 3052